Cambio - Excellence in Molecular Biology

Search
PCR

PCR : Rest DNA Testing

Detection of residual host cell DNA by dPCR with MiQuant® Residual DNA dPCR kits for E. coli, CHO or HEK-293:

  • Novel rapid, robust and sensitive method
  • Samples can be tested without performing DNA extraction
  • Meets EP, WHO and FDA criteria
  • Designed for use with the QIAGEN® QIAcuity® dPCR system
  • Aliquoted PCR mix ensures long-term stability
  • Lyophilized kit components simplify logistics and storage

 

Background & Description

Chinese hamster ovary cells (CHO), E. coli, and human embryonic kidney cells (HEK-293) have been widely used to manufacture recombinant proteins for human therapeutic use. After the synthesis of such immunotherapeutic or biosimilar, it is found that there could be some residual presence of DNA from the host cell. The World Health Organization (WHO), the Food and Drug Agency (FDA), and the European Pharmacopoeia (EP) recommend that the residual DNA in a manufactured final product needs to be less than 10 ng/dose. Even though downstream purification processes remove host cell residual DNA traces from products, testing for residual DNA is significant to ensure the customers’ safety.

The use of digital PCR (dPCR) is a very efficient way to determine the concentration of residual DNA in the final product. The MiQuant® Residual DNA dPCR kits for CHO, E. coli, and HEK-293 are the most accurate, efficient, and cost-effective way to analyze residual DNA in a sample without DNA extraction.

The kits are designed for QIAGEN®s QIAcuity® dPCR system as a novel rapid, robust, and sensitive method for absolute DNA quantification. This technology reduces the time needed for testing to less than three hours, including the dPCR sample preparation and thermocycling. Also, using these kits increases sensitivity since no DNA is lost during the extraction.

Short multicopy targets in the CHO (repeated element, ~ 1 million copies per genome), E. coli (7 genome copies), and HEK-293 (repeated element, ~ 1 million copies per genome) genomes are amplified. The length of the amplicons is < 200 bp and, therefore, short enough to allow the amplification of highly degraded DNA according to guidelines.

Moreover, each kit contains all the necessary PCR components, including Taq polymerase, primers, and dNTPs in a lyophilized mix, the Rehydration Buffer, dPCR Grade Water, and lyophilized Internal Control. The Internal Control is very reliable and will indicate any false negative result caused by PCR inhibition.

 

MiQuant® Residual DNA CHO – dPCR

Quantified genomic CHO DNA to support the dPCR-based determination of residual host-cell DNA. -Quantified gDNA from CHO cells -Supports method validation and process control -Enables conversion of dPCR results from [copies/µl] to [fg/µl]

Minerva Biolabs

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
58-0111MiQuant® Residual DNA dPCR CHO35 ul primer/probe mix POA Quantity
Add
58-0112MiQuant® Residual DNA dPCR CHO140 ul primer/probe mix POA Quantity
Add

MiQuant® Residual DNA CHO – dPCR

 

 

Digital PCR assay for the quantitative determination of residual host cell DNA from CHO cells.
- Direct testing without DNA extraction
- Meets EP, WHO, and FDA criteria
- Universally compatible with dPCR and ddPCR™ platforms

 

Product Description

CHO cells are established production cell lines for recombinant biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins. Residual CHO DNA is considered a process-related impurity and must be reliably quantified and controlled throughout the manufacturing process.

WHO and FDA guidelines define risk-based limits that depend, among other factors, on the cell substrate, route of administration, and the tumorigenic and oncogenic potential of the residual DNA. For certain parenterally administered products derived from non-tumorigenic cell lines, less than 10 ng of residual DNA per dose and DNA fragments of approximately 200 bp or smaller are used as reference values.

MiQuant® Residual DNA CHO - dPCR is a digital PCR assay for the quantitative determination of residual CHO DNA in chemical and biological matrices. The assay was developed for research and quality control in biopharmaceutical manufacturing processes.

Samples can be analyzed directly without prior DNA extraction. This reduces the total workflow to less than three hours and prevents potential DNA loss during purification.

By amplifying a short multicopy target sequence within the CHO genome, the assay enables the sensitive detection of highly fragmented or degraded CHO DNA. The assay achieves the quantification limit of 10 fg/µl described in Ph. Eur. 2.6.35.

Digital PCR enables direct sample analysis without prior DNA extraction. It also allows absolute quantification without the need for a standard curve. Using the dPCR Validation Standard CHO, a matrix-specific conversion factor can be determined to convert [copies/µl] into [fg/µl], enabling the quantification of residual DNA in accordance with applicable regulatory guidelines.

Specifications

Application Quantification of residual DNA from CHO host cells
Application areas
  • QC release of biopharmaceuticals and ATMPs
  • QC testing after purification steps
  • research applications
Contents
  • MiQuant® CHO Mix (lyophilized)
  • Positive Control DNA (lyophilized)
  • Internal Control DNA (lyophilized)
  • dPCR grade Water
Compliance EP 2.6.35, WHO, FDA
Validation report available
Time-to-result < 3 h
PCR type
  • digital PCR
  • digital droplet™ PCR
Compatible devices QIAcuity®, Quantstudio™ Absolute Q™, QX200™/QX600™ ddPCR™
Detection limit (LOD) ≤ 0.04 fg/μl
Target Chinese Hamster Ovary
Control system
  • Positive control
  • Internal control
Number of reactions
  • 58-0111:
    • QIAcuity® 26k plate: 8 reactions
    • QIAcuity® 8.5k plate: 26 reactions
    • QX200™/QX600™ ddPCR™: 16 reactions
    • Quantstudio™ Absolute Q™: 32 reactions
  • 58-0112:
    • QIAcuity® 26k plate: 32 reactions
    • QIAcuity® 8.5k plate: 106 reactions
    • QX200™/QX600™ ddPCR™: 64 reactions
    • Quantstudio™ Absolute Q™: 128 reactions
Price per reaction
  • 58-0111:
    • QIAcuity® 26k plate: €23,75
    • QIAcuity® 8.5k plate: €7,31
    • QX200™/QX600™ ddPCR™: €11,88
    • Quantstudio™ Absolute Q™: €5,94
  • 58-0112:
    • QIAcuity® 26k plate: €21,72
    • QIAcuity® 8.5k plate: €6,56
    • QX200™/QX600™ ddPCR™: €10,86
    • Quantstudio™ Absolute Q™: €5,43
Required equipment
and consumables
  • dPCR and ddPCR™ cycler with FAM™ and HEX™ detection channels, including the corresponding master mix and consumables
  • PCR reaction tubes
  • Centrifuge for 1.5 ml PCR reaction tubes
  • Vortex mixer
  • Pipettes with corresponding filter tips
Optional: dPCR Validation Standard CHO (Cat. No. 58-0211)
Storage 2-8 °C; ≤ –18 °C after rehydration
Shipping Ambient temperature
Shelf life (max.) 18 months

Regulatory Disclaimer

For research and industrial use only. Not for diagnostic or therapeutic use.

Minerva Biolabs offers a free sample of this product for testing:

Resources


 

 

 

 

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200